Final results from a phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2-overexpressing metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Dickler, M.; Franco, S.; Stopeck, A.; Ma, W.; Nulsen, B.; Lyandres, J.; Melisko, M.; Lahiri, S.; Arbushites, M.; Koehler, M.; Rugo, H. S. |
| Abstract Title: | Final results from a phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2-overexpressing metastatic breast cancer (MBC) |
| Meeting Title: | 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 69 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2008 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2009-01-15 |
| Start Page: | 242S |
| Language: | English |
| ACCESSION: | ISI:000262583201151 |
| PROVIDER: | wos |
| DOI: | 10.1158/0008-5472.SABCS-3133 |
| Notes: | --- - Meeting Abstract: 3133 - Suppl. S - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
